feed,title,long_url,short_url
r/covid19:100+,[Preprint] Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report,https://redd.it/hj9t0r,
